Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Y Tsai

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|December 31, 2015
When "Effective" Prevention Agents Fail to Elicit Anticipated Effects: Challenges in Trial DesignKenneth Y Tsai, Ernest T Hawk
Expert Opinion on Drug Safety|June 27, 2013
Drug safety evaluation of vemurafenib in the treatment of melanomaKenneth Y Tsai, Sasan Nowroozi, Kevin B Kim
Drug Delivery and Translational Research|March 20, 2015
Optimized lysis buffer reagents for solubilization and preservation of proteins from cells and tissuesByeong Hee Hwang, Kenneth Y Tsai, Samir Mitragotri
Seminars in Cancer Biology|June 5, 2019
MicroRNA heterogeneity in melanoma progressionAnita Thyagarajan, Kenneth Y Tsai, Ravi P Sahu
Journal of the American Academy of Dermatology|July 31, 2007
Nodular presentation of secondary syphilisKenneth Y Tsai, Thomas Brenn, Andrew E Werchniak
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 20, 2012
Diagnostic opportunities based on skin biomarkersSumit Paliwal, Byeong Hee Hwang, Kenneth Y Tsai, et al.
Drug Delivery and Translational Research|March 20, 2015
A reagent to facilitate protein recovery from cells and tissuesByeong Hee Hwang, Nishit Doshi, Kenneth Y Tsai, et al.
Journal of the American Academy of Dermatology|January 18, 2011
Kaposi sarcoma presenting as a cutaneous hornSirunya Silapunt, Robert E Jordon, Yingchao Piao, et al.
Evolutionary Applications|September 21, 2020
Integrating genetic and nongenetic drivers of somatic evolution during carcinogenesis: The biplane modelRobert A Gatenby, Stanislav Avdieiev, Kenneth Y Tsai, et al.
Molecular Carcinogenesis|June 14, 2019
Targeting ERK beyond the boundaries of the kinase active site in melanomaRachel M Sammons, Ranajeet Ghose, Kenneth Y Tsai, et al.
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
Cancer Prevention Research (Philadelphia, Pa.)|December 31, 2015
When "Effective" Prevention Agents Fail to Elicit Anticipated Effects: Challenges in Trial DesignKenneth Y Tsai, Ernest T Hawk
Expert Opinion on Drug Safety|June 27, 2013
Drug safety evaluation of vemurafenib in the treatment of melanomaKenneth Y Tsai, Sasan Nowroozi, Kevin B Kim
Drug Delivery and Translational Research|March 20, 2015
Optimized lysis buffer reagents for solubilization and preservation of proteins from cells and tissuesByeong Hee Hwang, Kenneth Y Tsai, Samir Mitragotri
Seminars in Cancer Biology|June 5, 2019
MicroRNA heterogeneity in melanoma progressionAnita Thyagarajan, Kenneth Y Tsai, Ravi P Sahu
Journal of the American Academy of Dermatology|July 31, 2007
Nodular presentation of secondary syphilisKenneth Y Tsai, Thomas Brenn, Andrew E Werchniak
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 20, 2012
Diagnostic opportunities based on skin biomarkersSumit Paliwal, Byeong Hee Hwang, Kenneth Y Tsai, et al.
Drug Delivery and Translational Research|March 20, 2015
A reagent to facilitate protein recovery from cells and tissuesByeong Hee Hwang, Nishit Doshi, Kenneth Y Tsai, et al.
Journal of the American Academy of Dermatology|January 18, 2011
Kaposi sarcoma presenting as a cutaneous hornSirunya Silapunt, Robert E Jordon, Yingchao Piao, et al.
Evolutionary Applications|September 21, 2020
Integrating genetic and nongenetic drivers of somatic evolution during carcinogenesis: The biplane modelRobert A Gatenby, Stanislav Avdieiev, Kenneth Y Tsai, et al.
Molecular Carcinogenesis|June 14, 2019
Targeting ERK beyond the boundaries of the kinase active site in melanomaRachel M Sammons, Ranajeet Ghose, Kenneth Y Tsai, et al.
Pageof 13